Author Affiliation: Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles.
Hay JW. What Is More Valuable: Fenofibrate Patents or Fenofibrate Clinical Outcomes? Arch Intern Med. 2012;172(19):1521–1522. doi:10.1001/archinternmed.2012.4386
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.